Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,573,586
+$164,821 QoQ
Shares Held
7,107
+3.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,137
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $48,413,418 across 14 Drug Manufacturers - General names. AMGN ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,543 | $12,645,591 | |
| 2 | ABBV |
AbbVie Inc.
|
40,073 | $10,083,969 | |
| 3 | JNJ |
Johnson & Johnson
|
27,094 | $6,881,063 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
46,311 | $5,850,931 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
94,459 | $5,442,727 | |
| 6 | AMGN |
Amgen Inc
This page
|
7,107 | $2,573,586 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,481 | $1,860,808 | |
| 8 | NVS |
Novartis AG
|
11,132 | $1,744,607 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,573,586 | 7,107 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,408,765 | 6,846 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,246,328 | 6,863 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,973,989 | 6,995 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,381,661 | 8,530 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $4,017,748 | 12,896 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,927,693 | 7,396 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,400,786 | 7,451 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,217,305 | 3,896 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $498,981 | 1,755 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $572,583 | 1,988 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $654,699 | 2,436 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $538,176 | 2,424 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $841,773 | 3,482 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $1,164,808 | 4,435 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $840,065 | 3,727 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,358,793 | 9,695 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,841,217 | 7,614 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,267,922 | 10,081 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,095,027 | 9,852 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,398,012 | 9,838 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $3,313,153 | 13,316 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $3,109,897 | 13,526 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $2,343,863 | 9,222 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $2,601,771 | 11,031 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $2,231,854 | 11,009 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||